within Pharmacolibrary.Drugs.ATC.M;

model M01AB16
  extends Pharmacokinetic.Models.PK_2C_enteral(
    weight         = 70,
    F              = 0.5,
    Cl             = 8.333333333333333e-05,
    adminDuration  = 600,
    adminMass      = 100 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.025,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.025,
    Tlag           = 600,            
    Vdp             = 0.017,
    k12             = 6.5,
    k21             = 6.5
    
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>M01AB16</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Aceclofenac is a nonsteroidal anti-inflammatory drug (NSAID) belonging to the phenylacetic acid derivatives class. It is primarily used for the symptomatic treatment of pain and inflammation in osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis. It is widely used and approved in several countries.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported for healthy adult volunteers after single oral dose.</p><h4>References</h4><ol><li><p>Kim, TH, et al., &amp; Shin, BS (2018). Pharmacokinetics and Anti-Gastric Ulceration Activity of Oral Administration of Aceclofenac and Esomeprazole in Rats. <i>Pharmaceutics</i> 10(3) –. DOI:<a href=\"https://doi.org/10.3390/pharmaceutics10030152\">10.3390/pharmaceutics10030152</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/30200587/\">https://pubmed.ncbi.nlm.nih.gov/30200587</a></p></li><li><p>Sharma, G, et al., &amp; Katare, OP (2017). Aceclofenac: Species-Dependent Metabolism and Newer Paradigm Shift from Oral to Non-oral Delivery. <i>Current topics in medicinal chemistry</i> 17(2) 107–119. DOI:<a href=\"https://doi.org/10.2174/1568026616666160530152958\">10.2174/1568026616666160530152958</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/27237333/\">https://pubmed.ncbi.nlm.nih.gov/27237333</a></p></li><li><p>Kumar, S, et al., &amp; Singh, S (2021). Novel Aceclofenac-l-Cystine and Aceclofenac-Urea Cocrystals with Enhanced Oral Bioavailability. <i>Current drug delivery</i> 18(8) 1174–1181. DOI:<a href=\"https://doi.org/10.2174/1567201818666210218103303\">10.2174/1567201818666210218103303</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/33602085/\">https://pubmed.ncbi.nlm.nih.gov/33602085</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end M01AB16;
